Home › Funds › ACUTA CAPITAL PARTNERS, LLC › IRD
ACUTA CAPITAL PARTNERS, LLC position in IRD
OPUS GENETICS INC · Health Care
ACUTA CAPITAL PARTNERS, LLC reported holding 514,110 shares of IRD (OPUS GENETICS INC) in its Q3 2026 13F filing — a position valued at US$2.5M, representing 1.96% of its reported portfolio and ranking #15 among its reported holdings. ACUTA CAPITAL PARTNERS, LLC first reported this position in Q3 2026.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ACUTA CAPITAL PARTNERS, LLC's IRD position evolved
ACUTA CAPITAL PARTNERS, LLC first disclosed a stake in IRD in Q3 2026 at 514,110 shares (US$2.5M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 514.11K | $2.49M | New |
About IRD and 13F data
IRD (OPUS GENETICS INC) is a Health Care company. 69 other funds we track also report a position in IRD — the largest reported positions include BIOS Capital Management, LP (US$17.83B), Caligan Partners LP (US$25.0M), Nantahala Capital Management, LLC (US$22.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IRD
- BIOS Capital Management, LP 3.68M sh · $17.83B · Q3 2026
- Caligan Partners LP 6.08M sh · $24.98M · Q2 2026
- Nantahala Capital Management, LLC 4.57M sh · $22.12M · Q3 2026
- Trails Edge Capital Partners, LP 2.41M sh · $11.67M · Q3 2026
- Boxer Capital Management, LLC 2.81M sh · $11.57M · Q2 2026
- GREAT POINT PARTNERS LLC 1.97M sh · $8.10M · Q2 2026
- Blue Owl Capital Holdings LP 969.61K sh · $4.69M · Q3 2026
- Opaleye Management Inc. 1.12M sh · $4.62M · Q2 2026
- Propel Bio Management, LLC 270.04K sh · $1.31M · Q3 2026
- Stonepine Capital Management, LLC 98.15K sh · $475.03K · Q3 2026
More on ACUTA CAPITAL PARTNERS, LLC
FAQ
How long has ACUTA CAPITAL PARTNERS, LLC held IRD?
ACUTA CAPITAL PARTNERS, LLC has disclosed IRD holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is ACUTA CAPITAL PARTNERS, LLC's current position in IRD?
As of Q3 2026, ACUTA CAPITAL PARTNERS, LLC holds 514.11K shares of IRD (OPUS GENETICS INC), valued at $2.49M, representing 1.96% of its reported portfolio and ranking #15.
Has ACUTA CAPITAL PARTNERS, LLC been buying or selling IRD?
In the latest 13F filing (Q3 2026), ACUTA CAPITAL PARTNERS, LLC newly opened its position in IRD.
Which other funds hold IRD?
Other major institutional holders of IRD include BIOS Capital Management, LP, Caligan Partners LP, Nantahala Capital Management, LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.